Detection and characterization of circulating epithelial tumor cells in patients with hepatocellular carcinoma (HCC)

被引：0
|
作者：
Berger, T. [1 ]
Kaufmann, R. [2 ]
Clement, J. H. [1 ]
Eberhardt, J. [3 ]
Malessa, C. [2 ]
Settmacher, U. [2 ]
Hochhaus, A. [1 ]
Wagner, K. [1 ]
机构：
[1] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Internist Onkol, Jena, Germany
[2] Univ Klinikum Jena, Klin Allgemein Viszeral & Gefasschirurg, Jena, Germany
[3] ALS Automated Labsolut GmbH, Jena, Germany
来源：
ONKOLOGIE | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [31] An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients
    Liu, Yong-kang
    Hu, Bao-shan
    Li, Zhong-liang
    He, Xu
    Li, Yong
    Lu, Li-gong
    HEPATOLOGY INTERNATIONAL, 2016, 10 (04) : 640 - 646
  • [32] Detection and phenotypic characterization of tumor spheres cultured from circulating epithelial tumor cells in patients with breast cancer
    Pizon, M.
    Zimon, D.
    Pachmann, U.
    Pachmann, K.
    ONKOLOGIE, 2013, 36 : 157 - 158
  • [33] Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
    Qianwei Ye
    Sunbin Ling
    Shusen Zheng
    Xiao Xu
    Molecular Cancer, 18
  • [34] Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
    Ye, Qianwei
    Ling, Sunbin
    Zheng, Shusen
    Xu, Xiao
    MOLECULAR CANCER, 2019, 18 (1)
  • [35] Detection of Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells in Patients with Esophageal Squamous Carcinoma
    Han, Dingpei
    Chen, Kai
    Che, Jiaming
    Hang, Junbiao
    Li, Hecheng
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [36] Molecular and functional characterization of circulating tumor cells in carcinoma patients
    Alix-Panabieres, Catherine
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)
    Abdelrahim, M.
    Esmail, A.
    He, A. R.
    Franses, J.
    Bhan, I.
    Victor, D. W.
    Kodali, S.
    Connor, A. A.
    Saharia, A.
    Brdiges, C.
    Tin, T.
    Brewer, C.
    Jurdi, A.
    Liu, M. C.
    Ghobrial, R. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S600 - S600
  • [38] Experience of detection of circulating tumor cells (CTCs) in patients with epithelial tumors
    Novikova, Inna Arnoldovna
    Kit, Oleg Ivanovich
    Bakhtin, Andrey Vladimirovich
    Maksimov, Aleksey Yurievich
    Chernikova, Elena N.
    Isaeva, Rukiyat
    Selyutina, Olesya N.
    Ulianova, Elena Petrovna
    Shvyrev, Dmitry Aleksandrovich
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Longitudinal and personalized detection of circulating tumor DNA (ctDNA) for monitoring efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma (HCC).
    Hsu, Chih-Hung
    Lu, Shan
    Abbas, Alex
    Guan, Yinghui
    Zhu, Andrew X.
    Aleshin, Alexey
    Lee, Kyung-Hun
    Lee, Michael Sangmin
    Mahipal, Amit
    Ryoo, Baek-Yeol
    Ding, Beiying
    Spahn, Jessica
    Verret, Wendy
    He, Aiwu Ruth
    Wang, Yulei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease
    Li, Y-M
    Xu, S-C
    Li, J.
    Han, K-Q
    Pi, H-F
    Zheng, L.
    Zuo, G-H
    Huang, X-B
    Li, H-Y
    Zhao, H-Z
    Yu, Z-P
    Zhou, Z.
    Liang, P.
    CELL DEATH & DISEASE, 2013, 4 : e831 - e831
12345